Vericel to Present at Canaccord Genuity Investor Conference
Feb 24, 2016 21:05 pm UTC| Business
CAMBRIDGE, Mass., Feb. 24, 2016 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today announced that it will...
Feb 24, 2016 21:05 pm UTC| Business
Relypsa reports encouraging initial demand for VeltassaVeltassa added to CMS 2016 Formulary Reference File and agreements signed with Express Scripts and CVS Caremark, the two largest pharmacy benefit managers in the...
Feb 24, 2016 21:05 pm UTC| Business
Fourth quarter revenues increase 8% to a record $298 millionFourth quarter Non-GAAP Economic EPS increases 12% to $1.31Estimated Remaining Collections increase to record $5.7 billionEncore deploys $345 million worldwide in...
Feb 24, 2016 21:05 pm UTC| Business
- Encore Cites Expanded Opportunities to Invest Capital for Greater Returns- Transaction Expected to Establish Propel’s Enterprise Value at More Than $340 Million- Sale Expected to Generate More Than $150 Million of...
Feb 24, 2016 21:05 pm UTC| Business
Full Year 2015 Highlights Reduced year-over-year capital expenditures by 41%, excluding acquisitions, while delivering record total productionIncreased year-over-year crude oil production by more than 14%Maintained...
Cempra Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
Feb 24, 2016 21:05 pm UTC| Business
CHAPEL HILL, N.C., Feb. 24, 2016 -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics in the face of rising antibiotic resistant bacterial infections, today reported...
Financial Institutions, Inc. Announces Quarterly Dividend
Feb 24, 2016 21:05 pm UTC| Business
WARSAW, N.Y., Feb. 24, 2016 -- Financial Institutions, Inc. (the “Company”) (NASDAQ:FISI) announced today that its Board of Directors has approved a quarterly cash dividend of $0.20 per outstanding common share. The...